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1. Introduction 
No more than 100 years ago, if a person acquired a bacterial infection, the body had to clear 
the infection by itself or else the infection would eventually result in death. After penicillin 
and many other effective antibiotics were discovered, however, that changed. In the decades 
after penicillin was discovered in 1928, a number of powerful antibiotics were developed. 
They were used plentifully and often carelessly prescribed needlessly for certain bacterial 
infections and even for viral infections where they have no effect. Farmers found that 
animals fed low levels of antibiotics grow faster and are less subject to disease, so thousands 
of tons of antibiotics were (and still are) added to animal feed. The problem: unlike 
disinfectants, antibiotics generally act against a single component of a bacterium. Thus, in 
environments where antibiotics are present, there is great selective pressure toward bacteria 
that can make the relatively minor mutations needed to render them resistant. Once a single 
bacterium has developed resistance to an antibiotic, it can be amplified across bacterial 
species by quick propagation and the tendency to share antibiotic resistance genes with 
other bacteria. In the last decade, resistance to antibiotics even antibiotics once thought to be 
“last ditch” treatments has increased remarkably and is continually on the rise. Doctors are 
finding many once-treatable infections are now deadly (e.g. highly publicized Methicillin-
resistant Staphylococcus aureus (MRSA) infections). Large pharmaceutical companies, once 
major sources of new antibiotics, have exhausted most “easy” targets for new antibiotics and 
have shifted their research and development focus to long-term, chronic diseases rather than 
antibiotic discovery to increase profits (Tanner, 2009).  
Antibacterial and antimicrobial are two similar concepts and sometimes they are used 
interchangeably; however there are some differences between them. Antibacterial: 
Anything that destroys bacteria or suppresses their growth or their ability to reproduce. 
Heat, chemicals such as chlorine, and antibiotic drugs all have antibacterial properties. 
Many antibacterial products for cleaning and hand washing are sold today. Such products 
do not reduce the risk for symptoms of viral infectious diseases in otherwise healthy 
persons. This does not preclude the potential contribution of antibacterial products to 
reducing symptoms of bacterial diseases in the home (Dorland Medical Dictionary, 2010). 
The term antibacterial is often used synonymously with the term antibiotic(s); today, 
however, with increased knowledge of the causative agents of various infectious diseases, 
antibiotic(s) has come to denote a broader range of antimicrobial compounds, including 
anti-fungal and other compounds.  
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Antimicrobial is a substance that kills or inhibits the growth of microorganisms (Merriam-
Webster Online Dictionary, 2009) such as bacteria, fungi, or protozoans. Antimicrobial 
drugs either kill microbes (microbiocidal) or prevent the growth of microbes 
(microbiostatic). Disinfectants are antimicrobial substances used on non-living objects or 
outside the body (Wikipedia, 2011). 
  
(a)     (b) 
Fig. 1. a) Scanning electron micrograph of S. aureus, 20,000 times enlargement, and false 
color added b) Bacterial cells of Staphylococcus aureus, which is one of the causal agents of 
mastitis in dairy cows. Its large capsule protects the organism from attack by the cow's 
immunological defenses (Kluytmans et al., 1997). 
2. How do antibacterial agents work? 
Most antimicrobial agents used for the treatment of bacterial infections may be categorized 
according to their principal mechanism of action. There are 5 major modes of action: (1) 
interference with cell wall synthesis, (2) inhibition of protein synthesis, (3) interference with 
nucleic acid synthesis, (4) inhibition of a metabolic pathway, and (5) Disruption of bacterial 
membrane structure. (Table 1.)(Neu, 1992). Antibacterial drugs that work by inhibiting 
bacterial cell wall synthesis include the b-lactams, such as the penicillins, cephalosporins, 
carbapenems, and monobactams, and the glycopeptides, including vancomycin and 
teicoplanin (McManus, 1997; Neu, 1992). β-Lactam agents inhibit synthesis of the bacterial 
cell wall by interfering with the enzymes required for the synthesis of the peptidoglycan 
layer. Vancomycin and teicoplanin also interfere with cell wall synthesis, but do so by 
binding to the terminal D-alanine residues of the nascent peptidoglycan chain, thereby 
preventing the cross-linking steps required for stable cell wall synthesis. Macrolides, 
aminoglycosides, tetracyclines, chloramphenicol, streptogramins, and oxazolidinones 
produce their antibacterial effects by inhibiting protein synthesis. Bacterial ribosomes differ 
in structure from their counterparts in eukaryotic cells. Antibacterial agents take advantage 
of these differences to selectively inhibit bacterial growth. Macrolides, aminoglycosides, and 
tetracyclines bind to the 30S subunit of the ribosome, whereas chloramphenicol binds to the 
50S subunit. Fluoroquinolones exert their antibacterial effects by disrupting DNA synthesis 
and causing lethal double-strand DNA breaks during DNA replication (Drlica & Zhao, 
1997), whereas sulfonamides and trimethoprim (TMP) block the pathway for folic acid 
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synthesis, which ultimately inhibits DNA synthesis (Petri, 2005; Yao & Moellering, 2003). 
The common antibacterial drug combination of TMP, a folic acid analogue, plus 
sulfamethoxazole (SMX) (a sulfonamide) inhibits 2 steps in the enzymatic pathway for 
bacterial folate synthesis. Disruption of bacterial membrane structure may be a fifth, 
although less well characterized, mechanism of action. It is postulated that polymyxins exert 
their inhibitory effects by increasing bacterial membrane permeability, causing leakage of 
bacterial contents (Storm et al., 1977). The cyclic lipopeptide daptomycin apparently inserts 
its lipid tail into the bacterial cell membrane (Carpenter & Chambers, 2004), causing 
membrane depolarization and eventual death of the bacterium. 
 
1. Interference with cell wall synthesis : 
- Lactams: penicillins, cephalosporins, carbapenems, monobactams 
- Glycopeptides: vancomycin, teicoplanin 
2. Protein synthesis inhibition 
- Bind to 50S ribosomal subunit: macrolides, chloramphenicol, clindamycin, 
quinupristin-dalfopristin, linezolid 
- Bind to 30S ribosomal subunit: aminoglycosides, tetracyclines 
- Bind to bacterial isoleucyl-tRNA synthetase: mupirocin 
3. Interference with nucleic acid synthesis 
- Inhibit DNA synthesis: fluoroquinolones 
- Inhibit RNA synthesis: rifampin 
4. Inhibition of metabolic pathway: sulfonamides, folic acid analogues 
5. Disruption of bacterial membrane structure: polymyxins, daptomycin 
Table 1. Mechanisms of action of antibacterial agents 
3. Methods for antibacterial activity 
3.1 Disk diffusion method 
Screening for antibacterial and antifungal activities are carried out using sterilized antibiotic 
discs (6 mm), following the procedure performance standards for Antimicrobial Disk 
Susceptibility Tests, outlined by the National Committee for Clinical Laboratory Standards 
NCCLS (Collins, 1989; Villonova, 1993).  
According to Disc Diffusion Method; when a filter paper disc impregnated with a chemical 
is placed on agar the chemical will diffuse from the disc into the agar. This diffusion will 
place the chemical in the agar only around the disc. The solubility of the chemical and its 
molecular size will determine the size of the area of chemical infiltration around the disc. If 
an organism is placed on the agar it will not grow in the area around the disc if it is 
susceptible to the chemical. This area of no growth around the disc is known as a “zone of 
inhibition”. 
Principle; antiseptics, disinfectants and antibiotics are used in different ways to combat 
microbial growth. Antiseptics are used on living tissue to remove pathogens. 
Disinfectants are similar in use but are used on inanimate objects. Antibiotics are 
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substances produced by living organisms, such as Penicillium or Bacillus, that kill or 
inhibit the growth of other organisms, primarily bacteria. Many antibiotics are chemically 
altered to reduce toxicity, increase solubility, or give them some other desirable 
characteristic that they lack in their natural form. Other substances have been developed 
from plants or dyes and are used like antibiotics. A better term for these substances is 
antimicrobials, but the term antibiotic is widely used to mean all types of antimicrobial 
chemotherapy. Many conditions can affect a disc diffusion susceptibility test. When 
performing these tests certain things are held constant so only the size of the zone of 
inhibition is variable. Conditions that must be constant from test to test include the agar 
used, the amount of organism used, the concentration of chemical used, and incubation 
conditions (time, temperature, and atmosphere). The amount of organism used is 
standardized using a turbidity standard. This may be a visual approximation using a 
McFarland standard 0.5 or turbidity may be determined by using a spectrophotometer 
(optical density of 1.0 at 600 nm). For antibiotic susceptibility testing the antibiotic 
concentrations are predetermined and commercially available. Each test method has a 
prescribed media to be used and incubation is to be at 35-37o C in ambient air for 18-24 
hours. The disc diffusion method for antibiotic susceptibility testing is the Kirby-Bauer 
method. The agar used is Meuller-Hinton agar that is rigorously tested for composition 
and pH. Further the depth of the agar in the plate is a factor to be considered in the disc 
diffusion method. This method is well documented and standard zones of inhibition have 
been determined for susceptible and resistant values. There is also a zone of intermediate 
resistance indicating that some inhibition occurs using this antimicrobial but it may not be 
sufficient inhibition to eradicate the organism from the body. 
The standardized methods for antiseptic and disinfectant testing are more rigorous and 
more difficult to reproduce in a student laboratory. Two common tests are the Phenol 
Coefficient Test (a comparison of the effect of the chemical and phenol on several 
organisms) and the Use Dilution Test (testing the chemical under actual conditions of use). 
A disc diffusion test can be used to approximate the Use Dilution Test. The chemical under 
consideration is used to saturate a filter paper disc. This disc is then used to introduce the 
chemical to the agar for testing. The actual zone sizes have not been standardized as in the 
Kirby-Bauer method, but a comparison of zone sizes for the same chemical among 
organisms will provide an approximate effectiveness of the chemical. 
3.2 Dilution method 
Screening for antibacterial and antifungal activities was carried out by preparing a broth 
micro dilution, following the procedure outlined in Manual of Clinical Microbial (Jones et 
al., 1985). The broth dilution method depends upon inoculation at a specific inoculum 
density of broth media (in tubes or microtitre plates) containing antibiotics at varying levels 
usually doubling dilutions are used and after incubation, turbidity is recorded either 
visually or with an automated reader, and the breakpoint concentration established. 
Microtitre plates or ready-to-use strips are commercially available with antibiotics ready 
prepared in the wells. A variation on this approach is the agar dilution method where a 
small volume of suspension is inoculated onto agar containing a particular concentration of 
antibiotic, when the inoculum has dried the plate is incubated and again examined for zones 
of growth. 
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Biological data: Standardized samples of Penicillin-g (blocking the formation of bacterial 
cell walls, rendering bacteria unable to multiply and spread; Ampicillin (penetrating and 
preventing the growth of Gram-negative bacteria); Cefotaxime (used against most Gram-
negative enteric bacteria); Vancomycin (acting by interfering with the construction cell walls 
in bacteria), Ofloxacin (entering the bacterial cell and inhibiting DNA-gyrase, which is 
involved in the production of genetic material, preventing the bacteria from reproducing); 
Tetracyclines (exerting their antimicrobial effect the inhibition of protein synthesis; Nystatin 
(binding to sterols in the fungal cellular membrane altering the permeability to allow 
leakage of the cellular contents and destroying the fungus); Ketoconazole (inhibiting the 
growth of fungal organisms by interfering with the formation of the fungal cell wall) and 
Clotrimazole (interfering with their cell membranes and causing essential constituents of the 
fungal cells leakage). Mueller Hinton media, Nutrient Broth and Malt Extract Broth are 
purchased from Difco and yeast extracts is obtained from Oxoid. 
4. Dendrimers as antibacterial or antimicrobial agents 
High molecular surface functional group concentration of dendrimers can dominate 
antibacterial properties to the interacting molecule. If the end or surface groups of 
dendrimers are functionalized with biologically active antimicrobial groups, we might 
expect an increase in antimicrobial activity of the dendrimers depending on the high 
molecular antimicrobial surface functional group increase on the surface of the molecule.  
The target for antimicrobials must be selected carefully. This is because of the fact that 
bulkier dendrimers may not be able to penetrate the cell membrane barrier and may have 
difficulty reaching the target site for the anticipated antimicrobial action (Chen & Cooper, 
2002).  
Biocides immobilized on dendrimers can be more effective if the target sites are cell walls 
and/ or membranes. It has been shown that small quaternary ammonium compounds exert 
their antimicrobial action by disrupting and disintegrating the cell membrane (Ghosh, 1988; 
Kourai et al., 1980; Panarin et al., 1985). Converting functional end groups of dendrimer to 
ammonium salts, dendrimer biocides can be synthesized. These dendrimer biocides have 
been shown to be more potent than their small molecule counterparts as they bear high local 
density active groups. Thus, dendrimer biocides may be very beneficial in terms of activity, 
localization in specific organs, reduced toxicity, and increased duration of action 
(Donaruma, 1978, 1980). 
As the bacteria are negatively charged and dendrimer biocides have high positive charge 
density, electrostatic interactions bring them into contact with each other. Depending on 
the concentration of the dendrimer biocides, membrane permeability can be slightly 
changed or denaturized. At the end, high concentrations of dendrimer biocides can lead 
to complete disintegration of the bacterial membrane causing to a bactericidal effect (Neu, 
1992). 
By adding water soluble functional end groups to dendrimers, water soluble dendrimers are 
obtained. When these dendrimers interacted with bacteriostatic weak water soluble or 
insoluble antibiotics, the antibacterial properties antibiotics can be altered, especially 
improved, and also clinical applications can be experimentally observed by conducting 
studies. Bacterial inflections remain major causes of mortality in hospitals all around the 
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world. Against these bacterial inflections including enteric and urinary tract, and respiratory 
tract, sulfonamides are widely used. They are preferred due to ease of administration and 
wide spectrum of anti-bacterial activity. However, the clinical use of sulfonamides is limited 
due to their extremely low solubility in water, rapid elimination in blood, low level of 
association to plasma proteins and several side effects. Microbiology studies showed that 
PAMAM dendrimers could increase water solubility and the anti bacterial activity of a kind 
of sulfonamide, Sulfamethoxazole (SMZ)(Fig. 2.) (a 4- or 8 fold increase in the antibacterial 
activity of SMZ in dendrimer solution compared to pure SMZ dissolved in dimethyl 
sulfoxide (DMSO) or 0.01 M NaOH solution) (Ma, et al., 2007). Likewise, Quinolones (Fig. 3.) 
which are expanding class of clinically established potent antibiotics are not freely soluble in 
water. Microbiological studies of the quinolones (nadifloxacin and prulifloxacin) showed 
that strong antimicrobial activities of nadifloxacin and prolifloxacin were still significantly 
increased in the presence of PAMAM dendrimers and also their water solubility increased 
(Cheng et al., 2007). 
 
 
Fig. 2. Structure of Sulfamethoxazole (SMZ) 4-amino-N-(5-methylisoxazol-3-yl)-
benzenesulfonamide 
 
 
Fig. 3. Essential structure of all quinolone antibiotics: R1 is usually piperazine; if the 
connection contains fluorine (F), it is a fluoroquinolone. 
Highly branched dendritic structures and unique properties of dendrimers have attracted 
great interest in the recent studies of antimicrobial activities of dendrimers and their 
derivatives (Chen & Cooper, 2000). In most cases, Dendrimers have the ability of carrying 
biologically active agents by encapsulating them in the interior or generally, attaching them on 
the periphery of dendrimers. For example, most dendrimers displaying antimicrobial activities 
are terminated with antimicrobial agents, including ferrocene (Abd-Elzaher & Ali, 2006), 
quaternary ammonium (Chen et al., 2000; Chen & Cooper, 2000, 2002), boron complexes (De 
Queiroz, 2006), carbohydrates (Rojo, 2004), and peptides (Bernstein et al., 2003, Bourne et al., 
2000; Janiszewska et al., 2006; Klajnert et al., 2006; Pini et al., 2005; Sechi et al., 2006).  
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Poly (amido amine) PAMAM (e.g, the generation 3 (G3) PAMAM in Fig. 4.) dendrimers are the 
most extensively studied dendrimers. PAMAM dendrimers with a wide variety of functional 
groups at the periphery are commercially available. Some of the dendrimers having terminal 
amino groups are shown as they are having low toxicity to eukaryotic cells (Malik et al., 2000; 
Roberts et al., 1996). Modification of the amino groups of the PAMAM dendrimers with poly 
(ethylene glycol) (PEG) or lauroly chains further improves the biocompatibility (Jevprasesphant 
et al., 2003a, 2003b; Luo et al., 2002). As the number of PEG or lauroyl chains increases, the 
cytotoxicity of PAMAM to human colon adenocarcinoma cells decreases (Jevprasesphant et al., 
2003). Shielding of the positive charges of the protonated amino groups on the exterior of the 
dendrimer by the PEG or lauroyl chains is likely the reason for reduced cytotoxicity 
(Jevprasesphant et al., 2003). Due to their excellent biocompatibility, PEG-modified PAMAM 
dendrimers have been used as carriers of imaging agents and pharmaceuticals, including 
antimicrobial agents such as penicillin V and silver (Aymonier et al., 2002; Balogh et al., 2001; 
Bielinska et al., 1996; Svenson & Tomalia, 2005; Yang & Lopina, 2003). 
 
Fig. 4. Structure of the G3 PAMAM dendrimer possessing ~32 amino groups at the 
periphery. 
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Even if mostly PAMAM dendrimers stated as the carriers or the modifiers of the 
antibacterial agents, it has been shown that PAMAM dendrimers themselves show 
antibacterial properties and they are highly toxic to some bacteria. They are also suggested 
PAMAM dendrimers as the antimicrobial agents because of the fact that PEG-coated 
PAMAM derivatives exhibited low toxicity to human corneal epithelial cells (Calabretta et 
al., 2007). Epidemiologic studies performed in Europe countries report an increase in 
infectious diseases and bacterial resistance to antibiotics. This has resulted in intensive 
world wide search for natural linear antimicrobial peptides and their derivatives. 
Antimicrobial peptides are 10 to 50 amino-acid-long peptide antibiotics that have been 
recently discovered in many living organism including humans. These peptides are an 
important part of the innate defense system. They are an important part of the innate 
defense system, possessing a high potency and broad spectrum of activity against 
prokaryotic cells with only a minor impact on eukaryotic cells. Such properties raised some 
hope that natural antimicrobial peptides and their synthetic analogs may be adaptable for 
use in vivo as new generation antibiotics (Lequin et al., 2003; Papo & Shai, 2003; Powers & 
Hancock, 2003).  
Active structures of linear peptides can be modeled by application of dendrimer chemistry. 
Dendrimers have nanoscopic dimensions having surface functional groups. Dendrimers can 
be synthesized by using organic chemistry methods and they can be indicated as the well 
suited compounds for biotechnological and biochemical applications. This is because of the 
fact that they can have multivalent nature, unambiguous composition, reliability and 
versatility in their synthesis. Eventually, antibacterial properties between two structurally 
different class of molecules- linear peptides and dendrimers can be transferred to attribute 
active conformation of amphiplic dendrimeric peptides (Janiszewska et al., 2007). 
There is a significant global need for new antibacterial and alternative mechanisms of action 
given the rise in resistance among bacteria (MacDougall & Polk, 2005; Mah & O’Toole, 
2005). Of the various known antibacterial agent classes, amphiphilic compounds act through 
perturbation and disruption of the prokaryotic membrane (Denyer, 1995). It has been 
hypothesized that amphiphilic anionic dendrimers may exhibit antibacterial activity with 
minimal eukaryotic cell cytotoxicity, since dendrimers with terminal anionic charges are 
generally noncytotoxic and have low toxicity in zebrafish whole animal development 
studies (Heiden, 2007). On the other hand, cationic dendrimers, some of which have 
antibacterial properties if the positive charge is properly shielded (Chen & Cooper, 2002), 
have repeatedly shown cytotoxicity against a variety of eukaryotic cell lines (Gurdag et al., 
2006; Hong et al, 2004). 
Apart from the cytotoxicity studies about the antimicrobial activities of the dendrimer 
integrated molecules, dendrimer studies also have come to a major interesting point in 
terms of many oral care products. Most of these products, especially toothpastes include 
Triclosan (TCN) (Fig. 5.) in order to prevent the bacterial growth called dental plague on the 
surface of the teeth. PAMAM dendrimers are of interest because they preferred in strategy 
in formulation to increase the delivery efficiency of antibacterial. TCN has broad spectrum 
antimicrobial activity against many types of Gram positive and Gram-negative non-
sporulating bacteria, some fungi and yeasts (Brading & Marsh, 2003). For an antibacterial to 
be effective when delivered from an oral care product it should be efficiently retained and 
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subsequently released at the site of interest. Dendrimers are good candidates for delivery 
systems as they can be modified by the addition of molecules to their surface groups. Active 
molecules either can be encapsulated or conjugated to surface groups. The surface groups 
also can be modified to enable specific targeting of the dendrimer carrier (Sampathkumar & 
Yarema, 2005). TCN is not an ionic molecule, itself. In theory, cationic dendrimers may have 
intrinsic mucoadhesive properties for use in the oral cavity, as mucin (which covers oral 
epithelia) is negatively charged (Hao & Heng, 2003), thus creating an electrostatic attraction 
between mucus and dendrimer. An agent such as TCN, when encapsulated in the 
dendrimer architecture may then be slowly released into the oral cavity, potentially 
increasing efficacy (Gardiner et al., 2008). 
 
 
Fig. 5. Structure of Triclosan 
Metal containing dendritic nanoparticles called as the Metallodendrimers. They are 
incorporated with metal atoms. Silver has known since ancient times as a very effective 
antimicrobial agent. Silver containing compounds and materials have been routinely used to 
prevent attack of a broad spectrum of microorganisms on prostheses (Gosheger et al., 2004), 
catheters (Semuel & Guggenbichler, 2004), vascular grafts (Strathmann & Wingender, 2004), 
human skin (Lee & Jeong, 2005), also used in medicine to reduce infection in burnt 
treatment (Parikh et al., 2005; Ulkur et al., 2005), arthroplasty (Alt, 2004). However they 
exhibit low toxicity to mammalian cells. The antibacterial activity of silver nanoparticles was 
tested against Bacillus subtilis and Staphylococcus aureus bacteria at different concentrations 
by using the diffusion disc technique. The results have showed that the antibacterial activity 
increases with the increase of concentration of the active agent (Mahapatra & Karak, 2008). 
An example demonstration of Nano-scaled silver interaction with bacteria cell can be shown 
from Fig. 6. 
The scope of Metallodendrimers has been developing by the interest of the antibacterial 
studies conducted by the application of them to different type of materials as in interaction. 
Silver complexes of dendrimers have a broad spectrum of preventing variety of 
microorganism attacks and so they are preferred as antibacterial study materials. For 
example, it has been shown that Dendrimers have been used as vehicle to develop the 
antimicrobial properties of textile fabrics by modifying (PAMAM) G3 dendrimer to provide 
antimicrobial properties. By accomplishing this, metal nanoparticles AgNO3-PAMAM (G3) 
complex as well as a MesoSilver-PAMAM (G3) complex has been formed and applied to 
Cotton/Nylon blend fabric. SEM analysis has shown that Dispersion of the silver 
nanoparticles onto the fabric (see Fig. 7. and Fig. 8.) was well and treated fabric against 
Staphylo-coccus aureus exhibited significantly biocide activities for each type of modified 
dendrimers (Ghosh et al., 2010).  
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Dispersion of organic/ inorganic hybrid materials could be utilized to form regular thin film 
coatings with antibacterial effects by using dendritic-polymer templates. The antibacterial 
activity of the coating films based on the hyper branched core/shell type hybrids and 
closely associated with the silver ions release of the films. The molecular architecture of the 
core/shell type hybrids used as hosts for silver nanoparticles can provide an improved 
control of the silver ion release and therefore an adjustment of the antibacterial affect 
specific to its application. This can be succeeded by the utility of the controllable generation 
structure of dendrimer nanoparticles (Gladitz et al., 2009). It has been shown that dendrimer 
films effectively inhibited the colonization of the Gramnegative bacteria Pseudomonas 
aeruginosa (strain PAO1) and, to a lesser extent, the Gram-positive bacteria Staphylococcus 
aureus (SA). Moreover, The antibacterial activity of the films was maintained even after 
storage of the samples in Phosphate Buffered Saline (PBS) for up to 30 days (Wang et al., 
2011). 
 
 
 
Fig. 6. Diagram summarizing nano-scaled silver interaction with bacterial cells. Nano-scaled 
silver may (1) release silver ions and generate reactive oxygen species (ROS); (2) interact 
with membrane proteins affecting their correct function; (3) accumulate in the cell 
membrane affecting membrane permeability; and (4) enter into the cell where it can 
generate ROS, release silver ions, and affect DNA. Generated ROS may also affect DNA, cell 
membrane, and membrane proteins, and silver ion release will likely affect DNA and 
membrane proteins (Marambio-Jones & Hoek, 2010).  
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Fig. 7. SEM image of the fabric treated with silver/ dendrimers complex at 1200 
magnification (10.0 kV and 10 mm distance) (Ghosh et al., 2010) 
 
Fig. 8. SEM image of MesoSilver–dendrimer composite treated-fabric (1200 mag) (Ghosh et 
al., 2010) 
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5. Conclusion 
It is clear that bacteria will continue to develop resistance to currently available antibacterial 
drugs by either new mutations or the exchange of genetic information, that is, putting old 
resistance genes into new hosts. In many healthcare facilities around the world, bacterial 
pathogens that Express multiple resistance mechanisms are becoming the norm, 
complicating treatment and increasing both human morbidity and financial costs. Prudent 
use of antibacterial drugs using the appropriate drug at the appropriate dosage and for the 
appropriate duration is one important means of reducing the selective pressure that helps 
resistant organisms emerge. The other vital aspect of controlling the spread of multidrug 
resistant organisms is providing sufficient personnel and resources for infection control in 
all healthcare facilities. New antibacterial agents with different mechanisms of action are 
also needed. It is difficult to outsmart organisms that have had several billion years to learn 
how to adapt to hostile environments, such as those containing antimicrobial agents. Yet, 
with sufficient efforts to use antimicrobial agents wisely, thereby preventing the emergence 
of resistant organisms, and strict attention to infection control guidelines to contain the 
spread of resistant organisms when they develop, we should be able to stay at least 1 step 
ahead of the next resistant plague. 
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